Even as many Americans line up for COVID-19 vaccines, others – including those who have previously expressed trust in the medical establishment and vaccines – have conveyed strong reservations. The reasons behind this hesitancy differ, but core concerns focus on the speed of development and its effect on vaccine quality and safety.
The Reagan-Udall Foundation for the FDA worked closely with the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research to better understand the perceptions that lead to COVID-19 vaccine hesitancy and to identify credible messages and messengers. Focused specifically on communication about FDA’s role in vaccine review and authorization/approval, the Vaccine Confidence Project aims to provide the vaccine-hesitant with the information they need to decide whether or not to receive a COVID-19 vaccine. View the Executive Summary Project Slide Deck.
The Vaccine Confidence Project began with listening. Our focus was to hear from front line workers and traditionally under-represented populations. We shared our then-work-in-progress with FDA’s Vaccines and Related Biological Products Advisory Committee in October 2020. You can watch the full Advisory Committee meeting here (Vaccine Confidence Project findings are at the 3:35:30 mark) and view our slide deck.